CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 
 

LGVN's Revenue Growth by Quarter and Year

Longeveron Inc 's Revenue results by quarter and year




LGVN Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.72 0.00 0.00
III Quarter September - 0.23 0.00 0.00
II Quarter June 0.47 0.49 0.00 0.00
I Quarter March 0.37 0.00 0.00 0.00
FY   0.84 0.00 0.00 0.00



LGVN Revenue second quarter 2022 Y/Y Growth Comment
Longeveron Inc reported decrease in Revenue in the second quarter 2022 by -4.9% to $ 0.47 millions, from the same quarter in 2021.
Despite modest results in the second quarter 2022, contraction in Longeveron Inc 's Revenue appears to be smaller than Company's recent average decline.

Looking into second quarter 2022 results within Major Pharmaceutical Preparations industry 156 other companies have achieved higher Revenue growth. While Longeveron Inc ' s Revenue decline of -4.9% ranks overall at the positon no. 3403 in the second quarter 2022.




LGVN Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June -4.9 % - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Longeveron Inc 's second quarter 2022 Revenue $ 0.47 millions LGVN's Income Statement
Longeveron Inc 's second quarter 2021 Revenue $ 0.49 millions Quarterly LGVN's Income Statement
New: More LGVN's historic Revenue Growth >>


LGVN Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - -53.06 % - -
II Quarter June 25.95 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #157
Healthcare Sector #511
Overall #3403

Revenue Y/Y Growth Statistics
High Average Low
-6.22 % -6.22 % -6.22 %
(Jun 30 2022)  
Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #157
Healthcare Sector #511
Overall #3403
Revenue Y/Y Growth Statistics
High Average Low
-6.22 % -6.22 % -6.22 %
(Jun 30 2022)  

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Longeveron Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
25.95 % -13.31 % -52.56 %
(Jun 30 2022)  


LGVN's II. Quarter Q/Q Revenue Comment
Longeveron Inc achieved in the II. Quarter 2022 above company average sequential Revenue jump of 25.95%, to $ 0.47 millions, from $0.37 millions in the first quarter.
Longeveron Inc is going from strength to strength, not just claiming better then normal gain, and also accelerating pace.

Within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue quarter on quarter growth. While Longeveron Inc 's Revenue growth quarter on quarter, overall rank is 686.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #62
Healthcare Sector #140
Overall #686
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #62
Healthcare Sector #140
Overall #686
Revenue Q/Q Growth Statistics
High Average Low
25.95 % -13.31 % -52.56 %
(Jun 30 2022)  


LGVN's II. Quarter Q/Q Revenue Comment
Longeveron Inc achieved in the II. Quarter 2022 above company average sequential Revenue jump of 25.95%, to $ 0.47 millions, from $0.37 millions in the first quarter.
Longeveron Inc is undergoing a remarkable growth, not just claiming above regular gain, and also increasing rate.

Within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue quarter on quarter growth. While Longeveron Inc 's Revenue growth quarter on quarter, overall rank is 686.


Longeveron Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 0.35 $ 0.35 $ 0.37 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -6.22 % -6.22 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3403 # 0 # 0 # 0 # 0




Cumulative Revenue growth Comment


Longeveron Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
-6.22 %
-6.22 %
-6.22 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 157
Sector # 511
S&P 500 # 3403
Cumulative Revenue growth Comment


Longeveron Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
-6.22 %
-6.22 %
-6.22 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 157
Sector # 511
S&P 500 # 3403




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LGVN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LGVN's Competitors
Revenue Growth for Longeveron Inc 's Suppliers
Revenue Growth for LGVN's Customers

You may also want to know
LGVN's Annual Growth Rates LGVN's Profitability Ratios LGVN's Asset Turnover Ratio LGVN's Dividend Growth
LGVN's Roe LGVN's Valuation Ratios LGVN's Financial Strength Ratios LGVN's Dividend Payout Ratio
LGVN's Roa LGVN's Inventory Turnover Ratio LGVN's Growth Rates LGVN's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2022
Edwards Lifesciences Corporation-0.15%$ -0.153 millions
Chemed Corporation-0.18%$ -0.182 millions
Ati Physical Therapy Inc -0.45%$ -0.451 millions
Berkeley Lights Inc -0.52%$ -0.519 millions
Organon and Co -0.63%$ -0.627 millions
Outset Medical Inc -0.63%$ -0.631 millions
Universal Security Instruments Inc-0.70%$ -0.700 millions
Accuray Incorporated-0.82%$ -0.823 millions
Travere Therapeutics Inc -0.82%$ -0.824 millions
Amedisys Inc-1.11%$ -1.112 millions
Teleflex Incorporated-1.25%$ -1.252 millions
Y mabs Therapeutics inc -1.41%$ -1.406 millions
Organogenesis Holdings Inc -1.46%$ -1.457 millions
Mimedx Group Inc -1.88%$ -1.881 millions
Central Garden and Pet Co-2.09%$ -2.092 millions
Acorda Therapeutics inc -2.31%$ -2.309 millions
Community Health Systems Inc -2.43%$ -2.428 millions
Alpha Pro Tech Ltd -2.43%$ -2.432 millions
Orthofix Medical Inc -2.74%$ -2.738 millions
3m Company-2.77%$ -2.771 millions
Teva Pharmaceutical Industries Limited-3.17%$ -3.171 millions
Neurometrix Inc -3.40%$ -3.397 millions
Royalty Pharma Plc-3.43%$ -3.425 millions
Bio rad Laboratories Inc -3.47%$ -3.468 millions
Healthlynked Corp-3.63%$ -3.630 millions
Talkspace Inc -3.68%$ -3.676 millions
Eli Lilly And Company-3.74%$ -3.740 millions
Laboratory Corporation Of America Holdings-3.74%$ -3.744 millions
Quest Diagnostics Inc-3.80%$ -3.804 millions
Livanova Plc-3.91%$ -3.906 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AEO's Profile

Stock Price

AEO's Financials

Business Description

Fundamentals

Charts & Quotes

AEO's News

Suppliers

AEO's Competitors

Customers & Markets

Economic Indicators

AEO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071